Published in Mol Cell Proteomics on December 14, 2011
Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One (2014) 1.29
Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development. Clin Transl Med (2014) 1.05
Aqueous two-phase system patterning of detection antibody solutions for cross-reaction-free multiplex ELISA. Sci Rep (2014) 0.91
Imaging flow cytometry: coping with heterogeneity in biological systems. J Histochem Cytochem (2012) 0.88
Bulked sample analysis in genetics, genomics and crop improvement. Plant Biotechnol J (2016) 0.84
Aqueous two-phase systems enable multiplexing of homogeneous immunoassays. Technology (Singap World Sci) (2014) 0.84
Toward development of a surface-enhanced Raman scattering (SERS)-based cancer diagnostic immunoassay panel. Analyst (2013) 0.83
A microfluidic platform for high-throughput multiplexed protein quantitation. PLoS One (2015) 0.78
Immunocapture strategies in translational proteomics. Expert Rev Proteomics (2015) 0.77
Serial analysis of 38 proteins during the progression of human breast tumor in mice using an antibody colocalization microarray. Mol Cell Proteomics (2015) 0.77
Deciphering the prokaryotic community and metabolisms in South African deep-mine biofilms through antibody microarrays and graph theory. PLoS One (2014) 0.76
Antibody-Based Assays for Phenotyping of Extracellular Vesicles. Biomed Res Int (2015) 0.75
A versatile snap chip for high-density sub-nanoliter chip-to-chip reagent transfer. Sci Rep (2015) 0.75
Fabrication of Homogeneous High-Density Antibody Microarrays for Cytokine Detection. Microarrays (Basel) (2014) 0.75
Three-Dimensionally Functionalized Reverse Phase Glycoprotein Array for Cancer Biomarker Discovery and Validation. J Am Chem Soc (2016) 0.75
Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A (1998) 192.97
A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med (2002) 58.15
Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature (2002) 45.19
Error and attack tolerance of complex networks Nature (2000) 27.90
BioGRID: a general repository for interaction datasets. Nucleic Acids Res (2006) 22.41
STRING 8--a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res (2008) 20.62
The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics (2002) 16.08
Stromal gene expression predicts clinical outcome in breast cancer. Nat Med (2008) 10.68
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol (2009) 9.67
Light-generated oligonucleotide arrays for rapid DNA sequence analysis. Proc Natl Acad Sci U S A (1994) 9.59
Global analysis of protein phosphorylation in yeast. Nature (2005) 7.46
Analysis of protein complexes using mass spectrometry. Nat Rev Mol Cell Biol (2007) 4.70
Integrated barcode chips for rapid, multiplexed analysis of proteins in microliter quantities of blood. Nat Biotechnol (2008) 4.40
Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat Biotechnol (2010) 4.04
A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat Biotechnol (2011) 2.91
A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease. Nat Biotechnol (2011) 2.44
Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy. Proc Natl Acad Sci U S A (2009) 2.33
Measurement and quality control issues in multiplex protein assays: a case study. Clin Chem (2009) 2.11
An evaluation of commercial fluorescent bead-based luminex cytokine assays. PLoS One (2008) 2.06
Antibody-based protein multiplex platforms: technical and operational challenges. Clin Chem (2009) 1.95
Interference in immunoassay. Ann Clin Biochem (1999) 1.91
Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res (1991) 1.68
Label-free technologies for quantitative multiparameter biological analysis. Anal Bioanal Chem (2009) 1.66
Comparison of multiplex immunoassay platforms. Clin Chem (2009) 1.61
Multianalyte immunoassay based on spatially distinct fluorescent areas quantified by laser-excited solid-phase time-resolved fluorometry. Clin Chem (1992) 1.61
Antibody-based proteomics: fast-tracking molecular diagnostics in oncology. Nat Rev Cancer (2010) 1.54
Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab (1996) 1.53
Leptin is a growth factor in cancer. J Surg Res (2004) 1.49
Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management. J Cell Biochem (2007) 1.48
Proteomics and diagnostics: Let's Get Specific, again. Curr Opin Chem Biol (2008) 1.40
Generation and validation of affinity reagents on a proteome-wide level. J Mol Recognit (2009) 1.29
The multiplex bead array approach to identifying serum biomarkers associated with breast cancer. Breast Cancer Res (2009) 1.28
Development and standardization of multiplexed antibody microarrays for use in quantitative proteomics. Proteome Sci (2004) 1.26
ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients. Clin Chem (1997) 1.26
Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays. Eur J Cancer (2008) 1.23
Development and validation of sandwich ELISA microarrays with minimal assay interference. J Proteome Res (2008) 1.23
Cancer screening: a mathematical model relating secreted blood biomarker levels to tumor sizes. PLoS Med (2008) 1.21
Proteomics retrenches. Nat Biotechnol (2010) 1.18
Minimum information about a protein affinity reagent (MIAPAR). Nat Biotechnol (2010) 1.10
Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases. Proc Natl Acad Sci U S A (2011) 1.09
Antibody suspension bead arrays within serum proteomics. J Proteome Res (2008) 1.08
Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer. J Transl Med (2009) 1.04
Osteopontin expression according to molecular profile of invasive breast cancer: a clinicopathological and immunohistochemical study. Int J Biol Markers (2008) 0.95
3D protein microarrays: performing multiplex immunoassays on a single chip. Anal Chem (2003) 0.94
Antibody array analysis of labelled proteomes: how should we control specificity? N Biotechnol (2011) 0.94
Affymetrix GeneChip system: moving from research to the clinic. Expert Rev Mol Diagn (2006) 0.89
Multiplexed immunoassays for the analysis of breast cancer biopsies. Anal Bioanal Chem (2010) 0.86
Quantification of glands and fat in breast tissue: an experimental determination. Ann Anat (2002) 0.85
Antibody-array interaction mapping, a new method to detect protein complexes applied to the discovery and study of serum amyloid P interactions with kininogen in human plasma. Mol Cell Proteomics (2009) 0.84
Transcriptional profiling: is it worth the money? Res Microbiol (2000) 0.80
Elevated plasma endoglin (CD105) predicts decreased response and survival in a metastatic breast cancer trial of hormone therapy. Breast Cancer Res Treat (2008) 0.79
Addressable nanowell arrays formed using reversibly sealable hybrid elastomer-metal stencils. Anal Chem (2010) 0.79
Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol (1994) 9.41
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology (1996) 8.82
A strategy to reveal high-frequency RFLPs along the human X chromosome. Am J Hum Genet (1984) 7.73
Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature (1984) 5.85
Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology (1997) 4.93
International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci (1997) 4.50
Mechanism of met oncogene activation. Cell (1986) 4.20
Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc Natl Acad Sci U S A (1987) 3.99
The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet (2000) 3.91
Activation of the primary visual cortex by Braille reading in blind subjects. Nature (1996) 3.91
Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain (1994) 3.57
The human met oncogene is related to the tyrosine kinase oncogenes. Nature (1985) 3.46
InIB-dependent internalization of Listeria is mediated by the Met receptor tyrosine kinase. Cell (2000) 3.31
Modulation of muscle responses evoked by transcranial magnetic stimulation during the acquisition of new fine motor skills. J Neurophysiol (1995) 3.27
Rapid plasticity of human cortical movement representation induced by practice. J Neurophysiol (1998) 3.26
Protein kinase C is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner. Curr Biol (1999) 3.25
Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction. Circulation (2010) 3.16
A physiological mechanism of bradykinesia. Brain (1980) 3.15
Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. Am J Psychiatry (1997) 3.02
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene (2009) 2.86
Dose standardisation of botulinum toxin. Lancet (1989) 2.83
Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015. Euro Surveill (2015) 2.77
Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol (1981) 2.74
EMG analysis of stereotyped voluntary movements in man. J Neurol Neurosurg Psychiatry (1975) 2.71
Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology (2004) 2.70
Spinal motor neuron excitability during the silent period after cortical stimulation. Electroencephalogr Clin Neurophysiol (1991) 2.68
Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol (1992) 2.53
The pathophysiology of primary dystonia. Brain (1998) 2.51
Thematic analysis of the experience of making a decision to place a family member with Alzheimer's disease in a special care unit. Res Nurs Health (2001) 2.49
Modulation of cortical motor output maps during development of implicit and explicit knowledge. Science (1994) 2.41
Optimal focal transcranial magnetic activation of the human motor cortex: effects of coil orientation, shape of the induced current pulse, and stimulus intensity. J Clin Neurophysiol (1992) 2.38
Functional relevance of cross-modal plasticity in blind humans. Nature (1997) 2.36
Novel vertebrate nucleoporins Nup133 and Nup160 play a role in mRNA export. J Cell Biol (2001) 2.35
Human motor evoked responses to paired transcranial magnetic stimuli. Electroencephalogr Clin Neurophysiol (1992) 2.27
Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Mol Cell (2001) 2.26
Pathophysiology of bradykinesia in Parkinson's disease. Brain (2001) 2.24
Feedforward ankle strategy of balance during quiet stance in adults. J Physiol (1999) 2.24
Nervous system reorganization following injury. Neuroscience (2002) 2.11
Magnetic stimulation: motor evoked potentials. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl (1999) 2.10
The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase. Mol Cell Biol (2000) 2.07
Ballistic flexion movements of the human thumb. J Physiol (1979) 2.06
Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport (1995) 2.06
Cognitive planning deficit in patients with cerebellar atrophy. Neurology (1992) 2.03
Activation of cdc42, rac, PAK, and rho-kinase in response to hepatocyte growth factor differentially regulates epithelial cell colony spreading and dissociation. Mol Biol Cell (2000) 2.00
Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol (2011) 1.98
Molecular mechanism for the Shp-2 tyrosine phosphatase function in promoting growth factor stimulation of Erk activity. Mol Cell Biol (2000) 1.94
Human corticospinal excitability evaluated with transcranial magnetic stimulation during different reaction time paradigms. Brain (2000) 1.91
Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing. Mol Cell Biol (1991) 1.90
Neural networks for Braille reading by the blind. Brain (1998) 1.88
Mechanisms of deafferentation-induced plasticity in human motor cortex. J Neurosci (1998) 1.88
Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex. Neurology (2000) 1.83
Mesial motor areas in self-initiated versus externally triggered movements examined with fMRI: effect of movement type and rate. J Neurophysiol (1999) 1.83
Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase. J Biol Chem (1995) 1.82
A C. elegans E/Daughterless bHLH protein marks neuronal but not striated muscle development. Development (1997) 1.81
Neural correlates of tic generation in Tourette syndrome: an event-related functional MRI study. Brain (2006) 1.81
Neural correlates of auditory-visual stimulus onset asynchrony detection. J Neurosci (2001) 1.80
Reticular reflex myoclonus: a physiological type of human post-hypoxic myoclonus. J Neurol Neurosurg Psychiatry (1977) 1.79
Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale. Neurology (2005) 1.79
Task-dependent changes of intracortical inhibition. Exp Brain Res (1998) 1.77
Postural adjustments associated with rapid voluntary arm movements 1. Electromyographic data. J Neurol Neurosurg Psychiatry (1984) 1.77
A positron emission tomographic study of auditory localization in the congenitally blind. J Neurosci (2000) 1.76
Identification of an atypical Grb2 carboxyl-terminal SH3 domain binding site in Gab docking proteins reveals Grb2-dependent and -independent recruitment of Gab1 to receptor tyrosine kinases. J Biol Chem (2000) 1.76
Motor reorganization after upper limb amputation in man. A study with focal magnetic stimulation. Brain (1991) 1.75
Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results. Biol Psychiatry (1996) 1.73
Adaptation to lateral displacement of vision in patients with lesions of the central nervous system. Neurology (1983) 1.72
A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women. Br J Obstet Gynaecol (1996) 1.71
Induction of visual extinction by rapid-rate transcranial magnetic stimulation of parietal lobe. Neurology (1994) 1.70
Modulation of practice-dependent plasticity in human motor cortex. Brain (2001) 1.70
Modeling other minds. Neuroreport (1995) 1.70
From Tpr-Met to Met, tumorigenesis and tubes. Oncogene (2007) 1.69
Effects of coil design on delivery of focal magnetic stimulation. Technical considerations. Electroencephalogr Clin Neurophysiol (1990) 1.69
Cortical reflex myoclonus. Neurology (1979) 1.68
New genes for male accessory gland proteins in Drosophila melanogaster. Insect Biochem Mol Biol (1997) 1.68
The Gab1 PH domain is required for localization of Gab1 at sites of cell-cell contact and epithelial morphogenesis downstream from the met receptor tyrosine kinase. Mol Cell Biol (1999) 1.67
Dextromethorphan decreases the excitability of the human motor cortex. Neurology (1998) 1.66
Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases. Proc Natl Acad Sci U S A (1988) 1.64
Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase. Mol Cell Biol (1993) 1.64
Effects of low-frequency transcranial magnetic stimulation on motor excitability and basic motor behavior. Clin Neurophysiol (2000) 1.63
Three additional DNA polymorphisms in the met gene and D7S8 locus: use in prenatal diagnosis of cystic fibrosis. J Pediatr (1987) 1.63
Treatment of focal dystonias of the hand with botulinum toxin injections. J Neurol Neurosurg Psychiatry (1989) 1.62
Reliability of the NINDS Myotatic Reflex Scale. Neurology (1996) 1.62
Spatial discrimination is abnormal in focal hand dystonia. Neurology (2000) 1.62
Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene. Cell Growth Differ (1990) 1.62
The functional neuroanatomy of simple and complex sequential finger movements: a PET study. Brain (1998) 1.62
Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936. Leukemia (2006) 1.62
Changes in mood and hormone levels after rapid-rate transcranial magnetic stimulation (rTMS) of the prefrontal cortex. J Neuropsychiatry Clin Neurosci (1996) 1.60
Cerebral structures participating in motor preparation in humans: a positron emission tomography study. J Neurophysiol (1996) 1.58
Role of the human motor cortex in rapid motor learning. Exp Brain Res (2001) 1.58
Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am J Pathol (1996) 1.58
Noninvasive mapping of muscle representations in human motor cortex. Electroencephalogr Clin Neurophysiol (1992) 1.57
Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas. Oncogene (1992) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Mechanisms of cortical reorganization in lower-limb amputees. J Neurosci (1998) 1.56
Acute anterior radiculitis associated with West Nile virus infection. J Neurol Neurosurg Psychiatry (2003) 1.55
Activation of the JNK pathway is essential for transformation by the Met oncogene. EMBO J (1997) 1.55
Simultaneous repetitive transcranial magnetic stimulation does not speed fine movement in PD. Neurology (1999) 1.54